Pregnancy outcomes in women with sickle cell disease in California
American Journal of Hematology · 2023-03 · 98 (3) · 440-448
DOI: 10.1002/ajh.26818 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, online erschienen am 04.01.2023. Verfasst von Oyebimpe O Adesina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Oncology Hematology Outcomes Research and Training, Division of Hematology Oncology, University of California Davis School of Medicine, Sa…. Hauptthemen laut MEDLINE: Pregnancy Complications, Hematologic, Anemia, Sickle Cell. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Adverse pregnancy outcomes occur frequently in women with sickle cell disease (SCD) across the globe. In the United States, Black women experience disproportionately worse maternal health outcomes than all other racial groups. To better understand how social determinants of health impact SCD maternal morbidity, we used California's Department of Health Care Access and Information data (1991–2019) to estimate the cumulative incidence of pregnancy outcomes in Black women with and without SCD—adjusted for age, insurance status, and Distressed Community Index (DCI) scores. Black pregnant women with SCD were more likely to deliver at a younger age, use government insurance, and live in at‐risk or distressed neighborhoods, compared to those without SCD. They also experienced higher stillbirths (26.8, 95% confidence interval [CI]: 17.5–36.1 vs. 12.4 [CI: 12.1–12.7], per 1000 births) and inpatient maternal mortality (344.5 [CI: 337.6–682.2] vs. 6.1 [CI: 2.3–8.4], per 100 000 live births). Multivariate logistic regression models showed Black pregnant women with SCD had significantly higher odds ratios (OR) for sepsis (OR 14.89, CI: 10.81, 20.52), venous thromboembolism (OR 13.60, CI: 9.16, 20.20), and postpartum hemorrhage (OR 2.25, CI 1.79–2.82), with peak onset in the second trimester, third trimester, and six weeks postpartum, respectively. Despite adjusting for sociodemographic factors, Black women with SCD still experienced significantly worse pregnancy outcomes than those without SCD. We need additional studies to determine if early introduction to reproductive health education, continuation of SCD‐modifying therapies during pregnancy, and increasing access to multidisciplinary perinatal care can reduce morbidity in pregnant women with SCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Oncology Hematology Outcomes Research and Training, Division of Hematology Oncology, University of California Davis School of Medicine, Sacramento, California, USA.
- Department of Medicine, University of California San Francisco School of Medicine, San Francisco, California, USA.
- Department of Obstetrics & Gynecology, Stanford University School of Medicine; Stanford Maternal & Child Health Research Institute, Stanford, California, USA.
- Division of Pediatric Pulmonary and Sleep Medicine, University of California, Davis School of Medicine, Sacramento, California, USA.
- UC Davis Clinical and Translational Science Center, University of California, Davis, California, USA.
ORCID-Profile: Oyebimpe O Adesina, Ann Brunson, Anjlee Mahajan
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- NICHD NIH HHS
- NCATS NIH HHS
- American Society of Hematology
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Center for Advancing Translational Sciences
- National Heart, Lung, and Blood Institute
Zitieren
APA
Adesina, O. O., Brunson, A., Fisch, S. C., Yu, B., Mahajan, A., Willen, S. M., Keegan, T. H. M., & Wun, T. (2023). Pregnancy outcomes in women with sickle cell disease in California. American Journal of Hematology, 98(3), 440-448. https://doi.org/10.1002/ajh.26818
Vancouver
Adesina OO, Brunson A, Fisch SC, Yu B, Mahajan A, Willen SM, et al. Pregnancy outcomes in women with sickle cell disease in California. American Journal of Hematology. 2023;98(3):440-448. doi:10.1002/ajh.26818
BibTeX
@article{Adesina2023,
author = {Adesina, Oyebimpe O and Brunson, Ann and Fisch, Samantha C and Yu, Bo and Mahajan, Anjlee and Willen, Shaina M and Keegan, Theresa H M and Wun, Ted},
title = {Pregnancy outcomes in women with sickle cell disease in California},
journal = {American Journal of Hematology},
year = {2023},
volume = {98},
number = {3},
pages = {440--448},
doi = {10.1002/ajh.26818}
}
EUVIMED